RecruitingNot ApplicableNCT05960890

Cohort Study of Chronic Heart Failure


Sponsor

Jiangsu Taizhou People's Hospital

Enrollment

1,000 participants

Start Date

Jun 8, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this observational study is to learn about the influencing factors of chronic heart failure prognosis in heart failure patients. The main question it aims to answer is that what are the influencing factors of clinical outcomes in chronic heart failure. Participants will be collected multiple omics data such as phenotype group, environmental exposure group, intestinal microbiome, genome, metabolome, and noninvasive biomarkers.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational cohort study is following people with chronic heart failure over time to better understand how the disease progresses and what factors affect long-term outcomes. Participants will be monitored through regular check-ins while being treated with standard oral medications. **You may be eligible if...** - You are 18 or older with a diagnosis of chronic heart failure, or newly diagnosed heart failure with abnormal heart function confirmed by echocardiogram and blood tests - Your heart failure is caused by dilated cardiomyopathy, high blood pressure, heart disease from blocked arteries, or mild valve disease - You are being treated with oral medications after hospital discharge **You may NOT be eligible if...** - You have very severe kidney disease (creatinine clearance below 30 ml/min) or are on dialysis - You have a correctable cause of heart failure (e.g., thyroid disease, severe anemia, significant valve disease) that has not been addressed - You need a pacemaker but haven't received one - You have COPD with Type 2 respiratory failure - You have a mental illness, are pregnant, or belong to another special population requiring different care considerations Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALRemote monitoring assisted by community physicians

Patients upload data such as wristband data, blood pressure, weight through their mobile phones, while physicians can check the data on the platform. Upon detecting alerts, community physicians review participant-related medical information, conduct structured symptom assessments via "StarNet Home" platform/phone within 2 hours, and initiate protocol-guided interventions (e.g., diuretic adjustment for fluid overload).


Locations(1)

Taizhou People's Hospital affiliated to Nanjing Medical University

Taizhou, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05960890


Related Trials